- Jan 5, 2016
Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday. This is the first Covid-19 vaccine in the United States to be assessed for full approval from the FDA.
Full approval will permit Pfizer to roll out yearly vaccines without any fuss. It will also make it easier for companies (and the like) to mandate vaccination as a condition of employment.